Chronic Cough Due to Gastroesophageal Reflux in Adults: CHEST Guideline and Expert Panel Report

Peter J. Kahrilas, Kenneth W. Altman, Anne B. Chang, Stephen K. Field, Susan M. Harding, Andrew P. Lane, Kaiser Lim, Lorcan McGarvey, Jaclyn A. Smith, Richard S. Irwin, Todd M. Adams, Kenneth W. Altman, Elie Azoulay, Alan F. Barker, Fiona Blackhall, Donald C Bolser, Louis Philippe Boulet, Christopher Brightling, Priscilla Callahan-Lyon, Brendan J CanningTerrie Cowley, Satoru Ebihara, Ali A. El Solh, Patricio Escalante, Stephen K. Field, Anthony Feinstein, Dina Fisher, Cynthia T. French, Peter Gibson, Philip Gold, Michael K. Gould, Cameron C. Grant, Susan M. Harding, Anthony Harnden, Adam T. Hill, Richard S. Irwin, Peter J. Kahrilas, Karina A. Keogh, Kefang Lai, Andrew P. Lane, Kaiser Lim, Mark A. Malesker, Stuart Mazzone, Lorcan McGarvey, M. Hassan Murad, Huong Q. Nguyen, Peter Newcombe, John J. Oppenheimer, Mark Rosen, Bruce Rubin, Jay H. Ryu, Jaclyn A. Smith, Susan M. Tarlo, Anne E. Vertigan, Gang Wang, Miles M. Weinberger, Kelly Weir

    Research output: Contribution to journalArticle

    Abstract

    Background: We updated the 2006 ACCP clinical practice guidelines for management of reflux-cough syndrome. 

    Methods: Two population, intervention, comparison, outcome (PICO) questions were addressed by systematic review: (1) Can therapy for gastroesophageal reflux improve or eliminate cough in adults with chronic and persistently troublesome cough? and (2) Are there minimal clinical criteria to guide practice in determining that chronic cough is likely to respond to therapy for gastroesophageal reflux? 

    Results: We found no high-quality studies pertinent to either question. From available randomized controlled trials (RCTs) addressing question #1, we concluded that (1) there was a strong placebo effect for cough improvement; (2) studies including diet modification and weight loss had better cough outcomes; (3) although lifestyle modifications and weight reduction may be beneficial in suspected reflux-cough syndrome, proton pump inhibitors (PPIs) demonstrated no benefit when used in isolation; and (4) because of potential carryover effect, crossover studies using PPIs should be avoided. For question #2, we concluded from the available observational trials that (1) an algorithmic approach to management resolved chronic cough in 82% to 100% of instances; (2) cough variant asthma and upper airway cough syndrome (UACS) (previously referred to as postnasal drip syndrome) from rhinosinus conditions were the most commonly reported causes; and (3) the reported prevalence of reflux-cough syndrome varied widely. 

    Conclusions: The panelists (1) endorsed the use of a diagnostic/therapeutic algorithm addressing causes of common cough, including symptomatic reflux; (2) advised that although lifestyle modifications and weight reduction may be beneficial in suspected reflux-cough syndrome, PPIs demonstrated no benefit when used in isolation; and (3) suggested that physiological testing be reserved for refractory patients being considered for antireflux surgery or for those in whom there is strong clinical suspicion warranting diagnostic testing.

    Original languageEnglish
    Pages (from-to)1341-1360
    Number of pages20
    JournalChest
    Volume150
    Issue number6
    DOIs
    Publication statusPublished - Dec 2016

    Fingerprint Dive into the research topics of 'Chronic Cough Due to Gastroesophageal Reflux in Adults: CHEST Guideline and Expert Panel Report'. Together they form a unique fingerprint.

    Cite this